Compare Niramas Utama Tbk. (JELI) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Niramas Utama Tbk. vs Merck Tbk. — how do they compare? Niramas Utama Tbk. trades at Rp515 (market cap 670.98B, 3.31M 24h volume), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Merck Tbk. is far larger — about 2.6× Niramas Utama Tbk.'s market cap, and Niramas Utama Tbk. is more actively traded (3.31M versus 63K). Which is the better fit depends on your goals.
| JELI | MERK | |
|---|---|---|
Market Cap | 670.98B | 1.76T |
Volume | 3.31M | 63K |
Lot | 33.07K | 630 |
Turnover | 1.71B | 243.97M |
Average Price | 516.6 | 3,872.46 |
Value | 1.71B | 243.97M |
Indicative Equilibrium Price | 515 | 3,900 |
Indicative Equilibrium Volume | 680 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Niramas Utama Tbk.
PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama
Read more on JELI →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
